Parameters | Recurrence(n = 30) | Non-recurrence(n = 72) | Statistical values | p-value |
---|---|---|---|---|
Age | 48.03 ± 14.31 | 51.99 ± 13.24 | 1.342 | 0.183 |
Sex | 1.077 | 0.299 | ||
Female | 19 (63.3%) | 53 (73.6%) | ||
Male | 11 (36.7%) | 19 (26.4%) | ||
Location | 0.413 | 0.521 | ||
Skull base | 8 (26.7%) | 15 (20.8%) | ||
Non skull base | 22 (73.3%) | 57 ( 79.2%) | ||
Necrosis | 0.596 | 0.440 | ||
Yes | 15 (50.0%) | 30 (41.7%) | ||
No | 15 (50.0%) | 42 (58.3%) | ||
Grade | 13.909 | 0.001 | ||
WHO 1 | 12 (40.0%) | 54 (75.0%) | ||
WHO 2 | 16 (53.3%) | 18 (25.0%) | ||
WHO 3 | 2 (6.7%) | 0 (0.0%) | ||
Enhancement | 4.870 | 0.027 | ||
Homogeneous | 6 (20.0%) | 31 (43.1%) | ||
Inhomogeneous | 24 (80.0%) | 41 (56.9%) | ||
Tumor shape | 2.857 | 0.091 | ||
Round | 12 (40.0%) | 42 (58.3%) | ||
Lobulation | 18 (60.0%) | 30 ( 41.7%) | ||
Tumor diameter | 4.24 ± 1.20 | 4.73 ± 1.27 | 1.798 | 0.075 |
Tumor volume | 208.97 ± 253.11* | 269.69 ± 367.00* | −1.447 | 0.148 |
Edema diameter | 0.00 ± 3.15* | 1.55 ± 3.80* | −0.912 | 0.362 |
Edema volume | 48.52 ± 11.62* | 56.22 ± 12.11* | −1.013 | 0.311 |
Edema index | 1.00 ± 1.80* | 1.00 ± 0.81* | −0.530 | 0.596 |
Ki−67 PI | 5.00 ± 17.00* | 3.00 ± 5.75* | −2.621 | 0.009 |
Simpson grade | 2.982 | 0.394 | ||
Simpson I | 4 (13.3%) | 17 (23.6%) | ||
Simpson II | 6 (20.0%) | 19 (26.4%) | ||
Simpson III | 11 (36.7%) | 23 (31.9%) | ||
Simpson IV | 9 (30.0%) | 13 (18.1%) | ||
Postoperative therapy | 1.772 | 0.183 | ||
Yes | 4 (13.3%) | 4 (5.6%) | ||
No | 26 (86.7%) | 68 (94.4%) | ||
CD8 + T cells (%) | 0.06 ± 0.13* | 0.17 ± 0.25* | −3.382 | 0.001 |